Frank Takkinen

Stock Analyst at Lake Street

(0.90)
# 3,897
Out of 4,989 analysts
62
Total ratings
26.32%
Success rate
-14.84%
Average return

Stocks Rated by Frank Takkinen

Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8$6
Current: $1.06
Upside: +466.04%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5$2
Current: $1.47
Upside: +36.05%
Sight Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $3$5
Current: $3.52
Upside: +42.05%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270$150
Current: $77.04
Upside: +94.70%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $12$8
Current: $1.82
Upside: +339.56%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.79
Upside: +122.43%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $22.87
Upside: +31.18%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6$5
Current: $1.41
Upside: +254.61%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19$14
Current: $7.45
Upside: +87.92%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16$15
Current: $12.46
Upside: +20.39%
Initiates: Buy
Price Target: $30
Current: $17.30
Upside: +73.41%
Maintains: Buy
Price Target: $17$26
Current: $17.85
Upside: +45.66%
Maintains: Buy
Price Target: $17$30
Current: $12.20
Upside: +145.90%
Maintains: Buy
Price Target: $4$5
Current: $4.03
Upside: +24.07%
Initiates: Buy
Price Target: $20
Current: $4.78
Upside: +318.41%
Initiates: Buy
Price Target: $5
Current: $2.40
Upside: +108.33%
Maintains: Buy
Price Target: $14$8
Current: $1.54
Upside: +419.48%
Maintains: Buy
Price Target: $28$30
Current: $41.10
Upside: -27.01%
Maintains: Buy
Price Target: $3$6
Current: $0.85
Upside: +605.80%
Maintains: Buy
Price Target: $3$4
Current: $2.93
Upside: +36.52%
Reiterates: Buy
Price Target: $12
Current: $10.39
Upside: +15.50%
Maintains: Buy
Price Target: $6$9
Current: $2.09
Upside: +330.68%
Maintains: Buy
Price Target: $14$16
Current: $2.42
Upside: +561.16%
Maintains: Buy
Price Target: $31$9.23
Current: $0.43
Upside: +2,031.64%